Abacavir and Lamivudine (REMEDYREPACK INC.)
Welcome to the PulseAid listing for the Abacavir and Lamivudine drug offered from REMEDYREPACK INC.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | REMEDYREPACK INC. |
NON-PROPRIETARY NAME: | Abacavir and Lamivudine |
SUBSTANCE NAME: | ABACAVIR SULFATE; LAMIVUDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-08-28 |
END MARKETING DATE: | 0000-00-00 |
Abacavir and Lamivudine HUMAN PRESCRIPTION DRUG Details:
Item Description | Abacavir and Lamivudine from REMEDYREPACK INC. |
LABELER NAME: | REMEDYREPACK INC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 600; 300(mg/1; mg/1) |
START MARKETING DATE: | 2017-08-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70518-0715_57d5fa8d-359a-9e2c-e053-2a91aa0a0b23 |
PRODUCT NDC: | 70518-0715 |
APPLICATION NUMBER: | ANDA204990 |
Other ABACAVIR SULFATE; LAMIVUDINE Pharmaceutical Manufacturers / Labelers: